• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

手术时间与美国甲状腺癌患者的生存

Time to Surgery and Thyroid Cancer Survival in the United States.

机构信息

Section of Endocrine Surgery, Department of Surgery, Beth Israel Deaconess Medical Center, Boston, MA, USA.

Harvard Medical School, Boston, MA, USA.

出版信息

Ann Surg Oncol. 2021 Jul;28(7):3556-3565. doi: 10.1245/s10434-021-09797-z. Epub 2021 Mar 25.

DOI:10.1245/s10434-021-09797-z
PMID:33768394
Abstract

BACKGROUND

Longer time to surgery worsens survival in multiple malignancies, including lung, colorectal, and breast cancers, but limited data exist for well-differentiated thyroid cancer. We sought to investigate the impact of time to surgery on overall survival in patients with papillary thyroid cancer.

METHODS

In a retrospective cohort study of the National Cancer Database, we used Cox proportional hazard models to investigate overall survival as a function of time between diagnosis and surgery for adults with papillary thyroid cancer, adjusting for demographic, patient, and cancer-related variables. Time to surgery was investigated both as a continuous variable and as intervals of 0-90 days, 90-180 days, and > 180 days. Subgroup analyses were conducted by T stage.

RESULTS

Overall, 103,812 adults with papillary thyroid cancer were included from 2004 to 2016. Median follow-up was 55.2 months (interquartile range 28.4-89.5). Increasing time to surgery was associated with increased mortality: delaying by 91-180 days increased the risk by 30% (adjusted hazard ratio [aHR] 1.30, 95% CI 1.19-1.43) and delaying by over 180 days increased the risk by 94% (aHR 1.94, 95% CI 1.68-2.24). Five-year overall survival was 95.7% for 0-90 days, 93.0% for 91-180 days, and 87.9% for over 180 days. On subgroup analysis, increasing delay was associated with worse overall survival for T1, T2, and T3 tumors, but not T4 tumors.

CONCLUSIONS

Increasing time to surgery in papillary thyroid cancer is associated with reduced overall survival. Further research is necessary to assess the impact of surgical delay on disease-specific survival.

摘要

背景

在多种恶性肿瘤中,包括肺癌、结直肠癌和乳腺癌,手术时间延长会降低生存率,但关于分化型甲状腺癌的数据有限。我们旨在研究手术时间对甲状腺乳头状癌患者总生存率的影响。

方法

在国家癌症数据库的回顾性队列研究中,我们使用 Cox 比例风险模型来研究甲状腺乳头状癌患者诊断与手术之间的时间对总生存率的影响,同时调整了人口统计学、患者和癌症相关变量。手术时间既作为连续变量进行研究,也作为 0-90 天、90-180 天和>180 天的间隔进行研究。进行了 T 分期的亚组分析。

结果

总体而言,2004 年至 2016 年期间纳入了 103812 名患有甲状腺乳头状癌的成年人。中位随访时间为 55.2 个月(四分位间距 28.4-89.5)。手术时间的延长与死亡率的增加相关:延迟 91-180 天会使风险增加 30%(调整后的危险比[aHR] 1.30,95%CI 1.19-1.43),而延迟超过 180 天会使风险增加 94%(aHR 1.94,95%CI 1.68-2.24)。0-90 天的 5 年总生存率为 95.7%,91-180 天为 93.0%,超过 180 天为 87.9%。在亚组分析中,对于 T1、T2 和 T3 肿瘤,延迟时间的增加与总生存率降低相关,但对于 T4 肿瘤则不然。

结论

在甲状腺乳头状癌中,手术时间的延长与总生存率降低有关。需要进一步研究来评估手术延迟对疾病特异性生存率的影响。

相似文献

1
Time to Surgery and Thyroid Cancer Survival in the United States.手术时间与美国甲状腺癌患者的生存
Ann Surg Oncol. 2021 Jul;28(7):3556-3565. doi: 10.1245/s10434-021-09797-z. Epub 2021 Mar 25.
2
Delay in Surgery and Papillary Thyroid Cancer Survival in the United States: A SEER-Medicare Analysis.美国手术延迟与甲状腺乳头状癌生存:一项 SEER-医疗保险分析。
J Clin Endocrinol Metab. 2023 Sep 18;108(10):2589-2596. doi: 10.1210/clinem/dgad163.
3
Predictors of Neck Reoperation and Mortality After Initial Total Thyroidectomy for Differentiated Thyroid Cancer.分化型甲状腺癌初次甲状腺全切除术后再次手术和死亡的预测因素。
Thyroid. 2018 Sep;28(9):1143-1152. doi: 10.1089/thy.2017.0483. Epub 2018 Jul 26.
4
Thyroid Lobectomy for T1b-T2 Papillary Thyroid Cancer with High-Risk Features.甲状腺叶切除术治疗 T1b-T2 伴有高危特征的甲状腺乳头状癌。
J Am Coll Surg. 2020 Jan;230(1):136-144. doi: 10.1016/j.jamcollsurg.2019.09.021. Epub 2019 Oct 28.
5
Age greater than 60 years portends a worse prognosis in patients with papillary thyroid cancer: should there be three age categories for staging?年龄大于 60 岁预示着甲状腺乳头状癌患者预后较差:分期是否应该分为三个年龄组?
BMC Cancer. 2018 Mar 22;18(1):316. doi: 10.1186/s12885-018-4181-4.
6
Association of Lymph Node Density With Survival of Patients With Papillary Thyroid Cancer.淋巴结密度与甲状腺乳头状癌患者生存的关系。
JAMA Otolaryngol Head Neck Surg. 2018 Feb 1;144(2):108-114. doi: 10.1001/jamaoto.2017.2416.
7
Mortality Risk of Nonoperative Papillary Thyroid Carcinoma: A Corollary for Active Surveillance.非手术治疗甲状腺乳头状癌的死亡率:主动监测的推论。
Thyroid. 2019 Oct;29(10):1409-1417. doi: 10.1089/thy.2019.0060. Epub 2019 Sep 24.
8
Total vs hemithyroidectomy for intermediate risk papillary thyroid cancer: A 23 year retrospective study in a tertiary center.全甲状腺切除术与甲状腺半切除术治疗中危甲状腺乳头状癌:一家三级中心 23 年回顾性研究。
Am J Otolaryngol. 2019 May-Jun;40(3):431-434. doi: 10.1016/j.amjoto.2019.04.001. Epub 2019 Apr 2.
9
Does microscopic positive tumor margin in papillary thyroid cancer really matter?甲状腺乳头状癌中肿瘤边缘镜下阳性真的重要吗?
Surgery. 2019 Dec;166(6):1160-1167. doi: 10.1016/j.surg.2019.07.021. Epub 2019 Sep 30.
10
Thyroid lobectomy is not sufficient for T2 papillary thyroid cancers.甲状腺叶切除术对于 T2 型甲状腺乳头状癌并不充分。
Surgery. 2018 May;163(5):1134-1143. doi: 10.1016/j.surg.2017.12.026. Epub 2018 Feb 13.

引用本文的文献

1
Short-term impact of delayed surgical treatment on the prognosis of patients with T1bN1-stage PTC: a retrospective cohort study.T1bN1期甲状腺乳头状癌患者延迟手术治疗对预后的短期影响:一项回顾性队列研究
BMC Cancer. 2025 May 27;25(1):950. doi: 10.1186/s12885-025-14371-x.
2
Impact of delayed surgery in differentiated thyroid carcinoma and medullary thyroid carcinoma.延迟手术对分化型甲状腺癌和髓样甲状腺癌的影响。
Endocrine. 2025 Apr 24. doi: 10.1007/s12020-025-04241-8.
3
Socioeconomic status and delayed surgery: impact on non-metastatic papillary thyroid carcinoma outcomes.

本文引用的文献

1
Time to Surgery and Colon Cancer Survival in the United States.美国的手术时间与结肠癌的生存情况。
Ann Surg. 2021 Dec 1;274(6):1025-1031. doi: 10.1097/SLA.0000000000003745.
社会经济地位与手术延迟:对非转移性乳头状甲状腺癌预后的影响。
Front Public Health. 2025 Jan 22;12:1488294. doi: 10.3389/fpubh.2024.1488294. eCollection 2024.
4
Thyroid cancer survival and prognostic factors in Yantai, China (2012-2022): a population-based study.中国烟台地区甲状腺癌的生存情况及预后因素(2012 - 2022年):一项基于人群的研究
BMC Cancer. 2024 Dec 30;24(1):1587. doi: 10.1186/s12885-024-13211-8.
5
Trends of the prevalence rate of central lymph node metastasis and multifocality in patients with low-risk papillary thyroid carcinoma after delayed thyroid surgery.低危型甲状腺乳头状癌患者延迟性甲状腺手术后中央区淋巴结转移和多灶性的流行率趋势。
Front Endocrinol (Lausanne). 2024 Apr 4;15:1349272. doi: 10.3389/fendo.2024.1349272. eCollection 2024.
6
A Cuproptosis-Related gene Signature as a Prognostic Biomarker in Thyroid Cancer Based on Transcriptomics.基于转录组学的铜死亡相关基因特征作为甲状腺癌的预后生物标志物
Biochem Genet. 2025 Apr;63(2):1584-1604. doi: 10.1007/s10528-024-10767-9. Epub 2024 Apr 9.
7
Racial implications of time to surgery in disparities in thyroid cancer survival.手术时间差异对甲状腺癌生存的种族影响。
Am J Surg. 2024 Aug;234:85-91. doi: 10.1016/j.amjsurg.2024.02.002. Epub 2024 Feb 27.
8
Disparities in Thyroid Cancer Diagnosis Based on Residence and Distance From Medical Facility.基于居住地和与医疗机构距离的甲状腺癌诊断差异。
J Endocr Soc. 2024 Feb 18;8(5):bvae033. doi: 10.1210/jendso/bvae033. eCollection 2024 Mar 12.
9
Screening tumor stage-specific candidate neoantigens in thyroid adenocarcinoma using integrated exome and transcriptome sequencing.利用整合外显子组和转录组测序筛选甲状腺腺癌肿瘤分期特异性候选新抗原。
Front Immunol. 2023 Oct 3;14:1187160. doi: 10.3389/fimmu.2023.1187160. eCollection 2023.
10
Insurance-Based Disparities in Guideline-Concordant Thyroid Cancer Care in the Era of De-escalation.保险对甲状腺癌治疗中降级趋势下符合指南规范差异的影响
J Surg Res. 2023 Sep;289:211-219. doi: 10.1016/j.jss.2023.03.046. Epub 2023 May 2.